Substance Use Disorders in Recently Hospitalized Patients With Cirrhosis.

J Addict Med

Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, CT (LYH, SJ); Yale School of Medicine, Yale Liver Center and Yale Center for Analytical Sciences, New Haven, CT (YD); Department of Biostatistics, Yale School of Public Health, New Haven, CT (MMC); Department of Internal Medicine, Section of General Internal Medicine, Yale School of Medicine, New Haven, CT (JMT).

Published: December 2020

Objectives: Cirrhosis is often a consequence of substance use disorders (SUD) and can lead to significant morbidity, mortality, and hospitalizations. We aimed to determine presence and impact of SUD in recently hospitalized patients with cirrhosis, which has not been previously described.

Methods: This is a retrospective study of consecutive patients with cirrhosis seen at a post-discharge hepatology clinic. The presence of clinically-recognized SUD and documented establishment of addiction treatment, as noted in routine clinical care, was determined through medical record review. Number of hospitalizations, 30-day readmissions, and all-cause mortality at 1 year were also examined.

Results: Among 99 patients, 72% were male and the median age was 55 years. The most common etiologies of cirrhosis were alcohol-related liver disease and hepatitis C infection. Alcohol use disorder was documented in 71%. Nearly all patients with clinically-recognized SUD underwent social work evaluation during hospitalization and 65% were referred to addiction treatment. Establishment of addiction care at follow up was documented in 35%. Documented SUD was associated with greater odds of hospitalization over 1 year (adjusted odds ratio 5.77, 95% confidence interval [1.36, 24.49], P = 0.017), but not with 30-day readmissions or mortality.

Conclusions: Clinically-recognized SUD was common in recently hospitalized patients with cirrhosis and associated with at least 1 other hospitalization within a year. Establishment of addiction treatment was documented in only a minority of patients. Further research is needed to determine whether patients with cirrhosis and SUD experience unique barriers to addiction treatment and if integration of SUD care in hepatology settings may be beneficial.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033633PMC
http://dx.doi.org/10.1097/ADM.0000000000000677DOI Listing

Publication Analysis

Top Keywords

patients cirrhosis
20
addiction treatment
16
hospitalized patients
12
clinically-recognized sud
12
establishment addiction
12
substance disorders
8
patients
8
sud
8
30-day readmissions
8
hospitalization year
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!